Atlas Trials

Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy

Clinical trial NCT02864615 · COMPLETED

Trial details

NCT number
NCT02864615
Sponsor
Kidney Cancer Research Bureau
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Renal Cell Carcinoma
Start date
2016-08-01
Primary completion
2018-01-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.